Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 2017
Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation
Luke R G Pike, Andrew Bang, Patrick Ott, et al.
Plos One
|
September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse, Meijuan Li, Jason Hughes, et al.
The Oncologist
|
November 7, 2022
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition
Eric A Severson, James Haberberger, Amanda Hemmerich, et al.
The Oncologist
|
May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
The Oncologist
|
September 12, 2020
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers
Andrew Rankin, Adrienne Johnson, Alison Roos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 5, 2020
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases
Richard S P Huang, James Haberberger, Eric Severson, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
JAMA
|
February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial
Ayal A Aizer, Kee-Young Shin, Paul J Catalano, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Urologic Oncology
|
July 3, 2021
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
Joseph Jacob, Andrea Necchi, Petros Grivas, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 2017
Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation
Luke R G Pike, Andrew Bang, Patrick Ott, et al.
Plos One
|
September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse, Meijuan Li, Jason Hughes, et al.
The Oncologist
|
November 7, 2022
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition
Eric A Severson, James Haberberger, Amanda Hemmerich, et al.
The Oncologist
|
May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
The Oncologist
|
September 12, 2020
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers
Andrew Rankin, Adrienne Johnson, Alison Roos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 5, 2020
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases
Richard S P Huang, James Haberberger, Eric Severson, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
JAMA
|
February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial
Ayal A Aizer, Kee-Young Shin, Paul J Catalano, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Urologic Oncology
|
July 3, 2021
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
Joseph Jacob, Andrea Necchi, Petros Grivas, et al.
Page
of 6